Skip to content

Not an actual patient.
Individual results may vary.

Proactively
treat
eczema

Eczema relief with Adbry

It can be frustrating when your is still not under control. Adbry™ (tralokinumab-ldrm) works inside the body to help get clearer skin and control the unbearable itch for the long-term. Adbry was used in 2 clinical trials for up to 1 year, and 1 trial for up to 8 months. Talk to your healthcare professional to see if Adbry is right for you.

Clearer skin

Adbry helped visibly improve the look and texture of skin at 4 months.

Image of woman’s back

Not an actual patient.
Individual results may vary.

Image of woman looking over shoulder

Not an actual patient.
Individual results may vary.

Less itch

Adults using Adbry experienced significantly less itch.

Maintained results

In all 3 clinical trials where adults used Adbry every other week, more patients experienced relief at 4 months, and maintained relief through the end of the trials, either at 8 months or 12 months.

Image of man with the words "eczema relief" on his arm

Not an actual patient. Individual results may vary.

How was Adbry studied in clinical trials?

Adbry was studied in 3 separate clinical trials of almost 2,000 adults aged 18 and older with moderate-to-severe  (). People in the trials injected 2 prefilled syringes every other week.

TRIAL 1: 601 people used Adbry; 197 used

TRIAL 2: 577 people used Adbry; 193 used

TRIAL 3: 243 people used Adbry + ; 123 used +

Clearer skin was measured in 2 ways:

  1. The percentage of people who saw CLEAR OR ALMOST CLEAR SKIN
  2. The percentage of people who saw a 75% OR BETTER IMPROVEMENT IN SKIN
Image of woman

Not an actual patient.
Individual results may vary.

Across Trials 1, 2, and 3, more people using Adbry saw a 90% or better improvement in their skin compared to those using .

Keep learning about Adbry:

Icon of Adbry™ (tralokinumab-ldrm) syringe
How to use Adbry